Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Debt (2018 - 2025)

TELA Bio (TELA) has 7 years of Total Debt data on record, last reported at $41.5 million in Q3 2025.

  • For Q3 2025, Total Debt rose 1.28% year-over-year to $41.5 million; the TTM value through Sep 2025 reached $41.5 million, up 1.28%, while the annual FY2024 figure was $41.1 million, 1.5% up from the prior year.
  • Total Debt reached $41.5 million in Q3 2025 per TELA's latest filing, roughly flat from $41.4 million in the prior quarter.
  • Across five years, Total Debt topped out at $41.5 million in Q3 2025 and bottomed at $31.5 million in Q4 2021.
  • Average Total Debt over 5 years is $40.0 million, with a median of $40.5 million recorded in 2023.
  • Peak YoY movement for Total Debt: rose 26.75% in 2022, then increased 1.28% in 2025.
  • A 5-year view of Total Debt shows it stood at $31.5 million in 2021, then rose by 26.75% to $39.9 million in 2022, then grew by 1.5% to $40.5 million in 2023, then grew by 1.5% to $41.1 million in 2024, then grew by 0.9% to $41.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $41.5 million in Q3 2025, $41.4 million in Q2 2025, and $41.3 million in Q1 2025.